Riskpilot← Back to searchSign inGet full accessC. Frosth Consulting AB
ABActiveOrg 5591639686Baldersgatan 2Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20180 employees
Revenue 2024
SEK 1,6M
+183% vs 2023
EBITDA margin
-1.3%
+98% vs 2023
Equity ratio
62.4%
Financial strength
Net profit 2024
SEK -1,2M
+57% vs 2023
| Revenue | SEK 1,6M | +183% |
| EBITDA | SEK -22K | +98% |
| Net profit | SEK -1,2M | +57% |
| Total assets | SEK 7M | -17% |
| Equity | SEK 4,3M | -21% |
| Employees | 0 | — |
Legal name
C. Frosth Consulting AB
Org number
5591639686
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1 juli 2018
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Frost, Gerda Cathrine
Company purpose
Bolaget ska bedriva konsultverksamhet inom apoteks- och läkemedelsbranschen, handel med värdepapper samt äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Baldersgatan 2
Email
cathrine@northvikingapartments.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 353 | 568 | 603 | 583 | 1 650 |
| Staff expenses | — | — | −862 | −830 | −794 |
| EBITDA | −2 298 | −2 254 | −1 461 | −1 205 | −21 |
| Depreciation & amort. | −609 | −730 | −954 | −1 056 | −1 082 |
| EBIT | −2 907 | −2 984 | −2 415 | −2 261 | −1 103 |
| Net financials | 3 049 | −67 | −1 804 | −432 | −66 |
| Profit before tax | 142 | −3 051 | −4 218 | −2 693 | −1 169 |
| Tax | −0 | −0 | — | — | — |
| Net profit | 142 | −3 051 | −4 218 | −2 693 | −1 169 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 18 885 | 15 404 | 11 154 | 8 447 | 6 973 |
| Equity | 15 479 | 12 428 | 8 210 | 5 517 | 4 348 |
| Long-term debt | 1 633 | 550 | 250 | 131 | 127 |
| Short-term debt | 1 773 | 2 426 | 2 694 | 2 799 | 2 498 |
| Total debt | 3 406 | 2 976 | 2 944 | 2 930 | 2 625 |
EBITDA margin
-1.3%
This company
15.8%
Market median
-108% vs market
20202024
Equity ratio
62.4%
This company
38.2%
Market median
+63% vs market
20202024
Return on equity
-26.9%
This company
18.4%
Market median
-246% vs market
20202024
Net profit margin
-70.9%
This company
8.1%
Market median
-975% vs market
20202024
Asset turnover
0.24×
This company
1.12×
Market median
-79% vs market
20202024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
GC Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
C. Frosth Consulting AB 
Sjöstadsapoteket ABBoard members of C. Frosth Consulting AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gerda Cathrine Frost | Chief Executive Officer | 0 companies |
| Clas Ola Hobér | Deputy Board Member | 0 companies |
| Dan Ola Alexander Hobér | Deputy Board Member | 0 companies |